Registry Study of Pregnancy and Breast Cancer

Launched by SPANISH BREAST CANCER RESEARCH GROUP · Oct 20, 2020

Keywords

ClinConnect Summary

This clinical trial, called the Registry Study of Pregnancy and Breast Cancer, is looking at how pregnancy affects women who have breast cancer. It aims to gather information from women who were diagnosed with breast cancer during pregnancy, breastfeeding, or within a year after giving birth, as well as those who became pregnant after their breast cancer treatment. The study is currently recruiting participants who are 18 years or older and have provided their consent to join.

If you join this study, you may share your experiences and data related to your breast cancer and pregnancy. This could help researchers understand the impact of breast cancer on pregnancy and the safety of treatments during this time. It’s important to know that if you don't want to participate for any reason, you won't be included in the study. By collecting this information, the trial hopes to improve care for women facing these challenges in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. The patient should have signed and dated the informed consent form (ICF). The enrollment of patients who have died is allowed.
• • 2. Women aged ≥ 18 years.
• 3. Patients in one of the following situations:
• • Patients with breast cancer diagnosis during pregnancy, breastfeeding or within the year after delivery.
• • Patients with breast cancer who become pregnant after treatment.
• • Patients with breast cancer who were subjected to any fertility preservation method prior to the start of breast cancer treatment.
• • 4. The patients referred to in the previous section and the patients who meet these characteristics prospectively could be enrolled retrospectively upon registry opening.
• • 5. All cases diagnosed at the same site may be included. In order to prevent duplications, in case the patient followed her treatment and follow-up at another site, she will be enrolled as per the site where the diagnosis was made, requesting information of the treatment and progression, when possible.
• • 6. Availability of clinical, epidemiological and progress data.
• Exclusion Criteria:
• • Patients who do not wish to participate in the study for any reason could not be included in the study.